Treatment of Postoperative Ileus After Bowel Surgery with Low-Dose Intravenous Erythromycin

Urology

Volumn 69, Issue 4, 2007, Pages 611-615

  Lightfoot, Andrew J ^a   Eno, Mary ^a   Kreder, Karl J ^a   O'Donnell, Michael A ^a   Rao, Satish S C ^a   Williams, Richard D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; PLACEBO;

ABDOMINAL PAIN; ANALYTIC METHOD; ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; COLON MOTILITY; COLON SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; DIARRHEA; DIET; DOUBLE BLIND PROCEDURE; FEMALE; FLATULENCE; HUMAN; ILEUS; INTERSTITIAL CYSTITIS; INTESTINE FUNCTION; INTESTINE SOUND; LOW DRUG DOSE; MALE; NAUSEA AND VOMITING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY DIVERSION;

DOUBLE-BLIND METHOD; ERYTHROMYCIN; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; ILEUS; INJECTIONS, INTRAVENOUS; INTESTINES; MALE; URINARY DIVERSION;

EID: 34147106116     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.12.027     Document Type: Article

References (26)

1. Holte K., and Kehlet H. Postoperative ileus: progress towards effective management. Drugs 62 (2002) 2603-2615
2. Kehlet H., and Holte K. Review of postoperative ileus. Am J Surg 18S (2001) S3-S10
3. Bungard T.J., and Kale-Pradhan P.B. Prokinetic agents for the treatment of postoperative ileus in adults: a review of the literature. Pharmacotherapy 19 (1999) 416-423
4. Chang S.S., Baumgartner R.G., Wells N., et al. Causes of increased hospital stay after radical cystectomy in a clinical pathway setting. J Urol 167 (2002) 208-211
5. Peeters T.L. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 105 (1993) 1886-1899
6. Catnach S.M., and Fairclough P.D. Erythromycin and the gut. Gut 33 (1992) 397-401
7. Kaul A. Erythromycin as a prokinetic agent. J Pediatr Gastroenterol Nutr 34 (2002) 13-15
8. Galligan J.J., and Vanner S. Basic and clinical pharmacology of new motility promoting agents. Neurogastroenterol Motil 17 (2005) 643-653
9. Itoh Z. Motilin and clinical application. Peptides 18 (1997) 593-608
10. Weber F.H., Richards R.D., and McCallum R.W. Erythromycin: a motilin agonist and gastrointestinal prokinetic agent. Am J Gastroenterol 88 (1993) 485-490
11. Hasler W.L. Pharmacotherapy for intestinal motor and sensory disorders. Gastroenterol Clin North Am 32 (2003) 707-732
12. Sarna S.K., Soergel K.H., Koch T.R., et al. Gastrointestinal motor effects of erythromycin in humans. Gastroenterology 101 (1991) 1488-1496
13. Coulie B., Tack J., Peeters T., et al. Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans. Gut 43 (1998) 395-400
14. Feighner S.D., Tan C.P., McKee K., et al. Receptor for motilin identified in the human gastrointestinal system. Science 284 (1999) 2184-2188
15. Longo W.E., and Vernava A.M. Prokinetic agents for lower gastrointestinal motility disorders. Dis Colon Rectum 36 (1993) 696-708
16. Bonacini M., Quiason S., Reynolds M., et al. Effect of intravenous erythromycin on postoperative ileus. Am J Gastroenterol 88 (1993) 208-211
17. Smith A.J., Nissan A., Lanouette N.M., et al. Prokinetic effect of erythromycin after colorectal surgery: randomized, placebo-controlled, double-blind study. Dis Colon Rectum 43 (2000) 333-337
18. Heyman S.N., Stalnikowicz R., Heyman A., et al. Erythromycin-induced dynamic ileus?. J Clin Gastroenterol 10 (1988) 551-554
19. Jameson J.S., Rogers J., Misiewicz J.J., et al. Oral or intravenous erythromycin has no effect on human distal colonic motility. Aliment Pharmacol Ther 6 (1992) 589-595
20. 2+ signaling induced by motilin and erythromycin in the circular smooth muscle of human colon. Neurogastroenterol Motil 13 (2001) 27-35
21. Strunz U., Domschke W., Mitznegg P., et al. Analysis of the motor effects of 13-norleucine motilin on the rabbit, guinea pig, rat, and human alimentary tract in vitro. Gastroenterology 68 (1975) 1485-1491
22. Kamerling I.M., Burggraaf J., van Haarst A.D., et al. The effect of motilin on the rectum in healthy volunteers. Br J Clin Pharmacol 55 (2003) 538-543
23. Bradette M., Poitras P., and Boivin M. Effect of motilin and erythromycin on the motor-activity of the human colon. J Gastrointest Motil 5 (1993) 247-251
24. Tack J., Janssens J., Vantrappen G., et al. Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology 103 (1992) 72-79
25. Kawamura O., Sekiguchi T., Kusano M., et al. Effect of erythromycin on interdigestive gastrointestinal contractile activity and plasma motilin concentration in humans. Dig Dis Sci 38 (1993) 870-876
26. Wolff B.G., Michelassi F., Gerkin T.M., et al. Alvimopan, a novel, peripherally acting μ-opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus. Ann Surg 240 (2004) 728-735